Price $137.51 |
Market Cap
48.59B
|
Sector Health Care |
Div. Growth
8.20%
|
|
P/E
40.5
|
P/B
8.92
|
P/S
7.6
|
Dividend %
0.50%
|
|
P/CF
-
|
P/FCF
46.2
|
Op. Cash Flow
1.49M
|
FCF
3.4
|
|
Op. Margin
21.30%
|
Net Margin
19.10%
|
ROE
24.30%
|
ROI
14.70%
|
|
ROA
11.70%
|
EPS Growth
71.70%
|
Current Ratio
2.2
|
Debt/Equity
50.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Viatris Inc (VTRS) | $14.53 | - | 3.30% | 16.39B | Strong Buy |
| Biomerica, Inc. (BMRA) | $4.37 | - | - | 48.8M | Strong Buy |
| Endo International PLC (ENDP) | $3.21 | - | - | 923M | Strong Buy |
| Puma Biotechnology Inc (PBYI) | $2.40 | - | - | 130M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $63.54 | - | 3.50% | 138.77B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
